Scholars Central

Conference abstractPublished 3 Aug 2015

Magnetic Nano Particle hyperthermia for deep sitting cancers therapy

Authors: Fridon Shubitidze

Dartmouth College, USA.

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Magnetic nano-particle hyperthermia (MNPH) is minimally invasive thermal technique for cancer therapy. One of main characteristics of MNPs for clinical hyperthermia is a high specific absorption rate (SAR), which depends on the applied magnetic field frequency, strength and MNP properties. During MNPH therapy a coil produces alternating electric and magnetic fields. The alternating magnetic field (AMF) penetrates inside tissue and activates MNPs in cancerous tissues, where else the alternating electric field produce undesirable eddy currents within normal tissue. Since, the AMF from a coil decays rapidly (as 1/R2); therefore, to use magnetic hyperthermia for deep tumors, such as pancreatic, prostate, rectum and etc cancers, a high-magnitude transmitter current is required in the coil. High transmitter currents also produce high electric fields E and eddy currents J within normal tissue that cause non-specific heating (J.E), which limits the applicability of MNP hyperthermia for deep sitting cancers. To overcome this problem, recently we have develop next generation Dartmouth MNP, with high SAR at low AMF strength, and a new device for guiding and delivering transmitted magnetic fields to deep tumors and for minimizing undesirable eddy currents heating in normal tissues. In this presentation, first the system’s AMF delivery and focusing performance will be described and illustrated using both modelled and measured data, then temperature distributions in a conducting phantom with and without the flexible magnetic device will be shown, and finally, applicability of the device for clinically MNPH therapy will be demonstrated in combination with the next generation MNP.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNanotechnology
  • SubjectOncology & Cancer
  • SubjectPhysics & Astronomy
  • BylineArticles whose byline prints “Fridon Shubitidze”